Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma

“

Gene silencing through Antisense oligonulceotides is cheap and has proved to be safe. This strategy is perfect for cancer immunotherapy, making this approach universal and accesible to every patient, in contrast to the expensive and not more efficient monoclonal antibodies.

”